Viking Therapeutics, Inc.
VKTXW
VKTXW was delisted on the 8th of April, 2021.
3 hedge funds and large institutions have $781K invested in Viking Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
4% more capital invested
Capital invested by funds: $751K → $781K (+$30K)
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$72.6K |
| 2 |
William Blair & Company
Chicago,
Illinois
|
-$39K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.68K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PWAM
1
Park West Asset Management
San Francisco,
California
| $623K | – | – | – |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $139K | -$72.6K | -12,404 | -37% |
|
|
3
UBS Group
Zurich,
Switzerland
| $19K | -$4.68K | -800 | -22% |
|
|
4
William Blair & Company
Chicago,
Illinois
| – | -$39K | -7,200 | Closed |
|
VKTXW Hedge Fund Activity: Q4 2019 in Review
3 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics, Inc. (VKTXW) for Q4 2019, worth a combined $781K — up 4% from $751K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of VKTXW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 0 added.
The largest seller was Susquehanna International Group, cutting an estimated $72.6K.
- 3 institutional investors held Viking Therapeutics, Inc. (VKTXW) as of Q4 2019, down from 4 in Q3 2019.
- Funds reported $781K of Viking Therapeutics, Inc. stock for Q4 2019, up 4% quarter-over-quarter.
- 0 funds opened new Viking Therapeutics, Inc. positions in Q4 2019 and 1 closed out, a net change of -1 holder.
- The largest Viking Therapeutics, Inc. seller in Q4 2019 was Susquehanna International Group, an estimated $72.6K sold.
Based on aggregated 13F filings for Q4 2019.